Clinical trial
A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of…
NCT00114946 · Genentech, Inc., Industry · Terminated
Key facts
| NCT number | NCT00114946 |
|---|---|
| Title | A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer |
| Official title | A Randomized, Open-Label Trial Comparing Two Avastin (Bevacizumab)-Based Treatment Regimens for the First-Line Treatment of Metastatic Colorectal Cancer |
| Lead sponsor | Genentech, Inc., Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Avastin |
| Enrollment | 800 |
| Start date | May 1, 2005 |
| Completion | Dec 1, 2007 |
| First posted | Jun 21, 2005 |
| Last update posted | May 29, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: